TrialJournal of clinical psychopharmacology
Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia: Results From the Phase 3 Program.
Anne Andorn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
pooled ittrialcites it